Sputnik V Studies Should Begin Shortly After ANVISA Approval

Brazilian pharmaceutical company União Química's goal is for the vaccine to be part of the PNI (National Immunization Plan). As such, it would be offered by the Ministry of Health to all states.

RIO DE JANEIRO, BRAZIL - The Russian Sputnik V vaccine for Covid-19 is already registered in its country of origin, as well as authorized for emergency use in other countries, including Argentina, Bolivia, Venezuela and Hungary.

União Química chairman Fernando Marques announced on Monday, January 25th that he plans to immediately start phase 3 trials of the Sputnik V vaccine in Brazil after ANVISA (National Health Regulatory Agency) clearance.

The Subscribe to our Premium Membership Plan. Already Subscribed?